Opioid antagonists

Results: 206



#Item
141Ketones / Alcohols / Opioid antagonists / Euphoriants / Naloxone / Methadone / Opioid / Hydrocodone / Drug overdose / Chemistry / Organic chemistry / Morphinans

The Commonwealth of Massachusetts Executive Office of Health and Human Services Department of Public Health Bureau of Health Care Safety and Quality

Add to Reading List

Source URL: www.mass.gov

Language: English - Date: 2014-03-27 18:10:19
142Table 2:  Empirical Guidelines for Opioid Rotation

Table 2: Empirical Guidelines for Opioid Rotation

Add to Reading List

Source URL: www.stoppain.org

Language: English - Date: 2005-06-03 18:45:32
143[removed]Federal Register / Vol. 76, No[removed]Thursday, November 17, [removed]Notices Dated: November 9, 2011. John Howard,

[removed]Federal Register / Vol. 76, No[removed]Thursday, November 17, [removed]Notices Dated: November 9, 2011. John Howard,

Add to Reading List

Source URL: www.gpo.gov

Language: English - Date: 2013-05-23 10:49:06
144DRUG RISK BEHAVIORS AND ALCOHOL USE IN RUSSIAN HEROIN USERS

DRUG RISK BEHAVIORS AND ALCOHOL USE IN RUSSIAN HEROIN USERS

Add to Reading List

Source URL: www.fda.gov

Language: English
145Declaration of Public Health Emergency Update   Commissioner Cheryl Bartlett, R.N.  Public Health Council  April 9,  2014

Declaration of Public Health Emergency Update   Commissioner Cheryl Bartlett, R.N.  Public Health Council April 9,  2014

Add to Reading List

Source URL: blog.mass.gov

Language: English - Date: 2014-04-09 14:43:38
146Ketones / Alcohols / Morphinans / Opioid antagonists / Alkenes / Naloxone / Methadone / Opioid / Drug overdose / Chemistry / Organic chemistry / Medicine

TESTIMONY RELATIVE TO EMERGENCY AMENDMENTS TO 105 CMR[removed]AND 105 CMR[removed]

Add to Reading List

Source URL: www.mass.gov

Language: English - Date: 2014-04-28 13:39:33
147Strategies to Address Barriers to & Concerns With Implementing Overdose Prevention Including Naloxone Distribution/Prescription (OPND) in Opiate Treatment Programs Logistical Barriers and Concerns  Questions to Consider

Strategies to Address Barriers to & Concerns With Implementing Overdose Prevention Including Naloxone Distribution/Prescription (OPND) in Opiate Treatment Programs Logistical Barriers and Concerns Questions to Consider

Add to Reading List

Source URL: prescribetoprevent.org

Language: English - Date: 2012-11-13 22:34:03
148Original Research  Annals of Internal Medicine Cost-Effectiveness of Distributing Naloxone to Heroin Users for Lay Overdose Reversal

Original Research Annals of Internal Medicine Cost-Effectiveness of Distributing Naloxone to Heroin Users for Lay Overdose Reversal

Add to Reading List

Source URL: prescribetoprevent.org

Language: English - Date: 2014-02-10 16:37:00
149C-1  Alvimopan— Retrospective Evaluation of Opioid Withdrawal and Cardiovascular Safety With Long-term Use in Opioid-Induced Constipation

C-1 Alvimopan— Retrospective Evaluation of Opioid Withdrawal and Cardiovascular Safety With Long-term Use in Opioid-Induced Constipation

Add to Reading List

Source URL: www.fda.gov

Language: English
150Alvimopan Cubist Pharmaceuticals, Inc. FDA Advisory Committee Briefing Package April 29, 2014

Alvimopan Cubist Pharmaceuticals, Inc. FDA Advisory Committee Briefing Package April 29, 2014

Add to Reading List

Source URL: www.fda.gov

Language: English